Literature DB >> 25904448

A changing landscape: diagnosis and management of COPD.

Steve Holmes1, Jane Scullion.   

Abstract

Chronic obstructive pulmonary disease (COPD) is a common and often particularly debilitating disease. Progressively worsening breathlessness can limit normal daily functioning, reduce quality of life (QoL) and increase the risk of premature death. Importantly, early diagnosis, improving symptoms and QoL, along with minimising exacerbations and hospital admissions, are primary goals of patient care. In recent years, the assessment of COPD has moved away from equating disease severity solely with the degree of obstructive lung impairment to include patient symptoms, exacerbation history and comorbidities, as well as smoking status. There are now more therapies that reduce symptoms and prevent exacerbations, thereby improving QoL. This review explores the diagnosis and management of COPD and positive clinical approaches to managing patients.

Entities:  

Keywords:  Assessment; Breathlessness; COPD; Management; Primary care; Quality of life

Mesh:

Substances:

Year:  2015        PMID: 25904448     DOI: 10.12968/bjon.2015.24.8.432

Source DB:  PubMed          Journal:  Br J Nurs        ISSN: 0966-0461


  3 in total

1.  COPD exacerbations by disease severity in England.

Authors:  Evie Merinopoulou; Mireia Raluy-Callado; Sreeram Ramagopalan; Sharon MacLachlan; Javaria Mona Khalid
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-04-01

2.  Sociodemographic and clinical factors affecting the quality of life of patients with chronic obstructive pulmonary disease.

Authors:  Joanna Rosińczuk; Maria Przyszlak; Izabella Uchmanowicz
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-09-12

3.  Striving for Confidence and Satisfaction in Everyday Life with Chronic Obstructive Pulmonary Disease: Rationale and Content of the Tele-Rehabilitation Programme >C☺PD-Life>>.

Authors:  Charlotte Simonÿ; Claus Riber; Uffe Bodtger; Regner Birkelund
Journal:  Int J Environ Res Public Health       Date:  2019-09-09       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.